doi: 10.1586/1744666X.3.2.145.
Hepatitis C: the complications of immune dysfunction
Affiliations
- PMID: 20477104
- DOI: 10.1586/1744666X.3.2.145
Item in Clipboard
Hepatitis C: the complications of immune dysfunction
Expert Rev Clin Immunol.
2007 Mar.
Abstract
Hepatitis C virus (HCV) infection has been linked to numerous diseases of immune dysfunction, including, but not limited to, essential mixed cryoglobulinemia and non-Hodgkin's lymphoma. Clinical studies support these associations and treatment of the underlying HCV infection has been variably successful. Recent studies, focusing on the role of HCV gene products, have discovered evidence of dysregulated responses in multiple aspects of host immunity that may be contributing to the genesis of these diseases. Novel treatments that target these areas of dysregulation offer hope for improved therapy for the diseases associated with immunodysregulation by HCV.
Similar articles
-
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.Haematologica. 2004 Jan;89(1):70-6. Haematologica. 2004. PMID: 14754608
-
Hepatitis C virus and non-Hodgkin's lymphoma 10 years later.Dig Liver Dis. 2005 Apr;37(4):219-26. doi: 10.1016/j.dld.2005.01.003. Dig Liver Dis. 2005. PMID: 15788203 Review.
-
Hepatitis C and lymphoproliferative disorders: from mixed cryoglobulinemia to non-Hodgkin's lymphoma.Clin Gastroenterol Hepatol. 2009 Aug;7(8):900-5. doi: 10.1016/j.cgh.2009.03.035. Epub 2009 Apr 9. Clin Gastroenterol Hepatol. 2009. PMID: 19362606 Review.
-
Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.Am J Hematol. 2001 Jul;67(3):168-71. doi: 10.1002/ajh.1101. Am J Hematol. 2001. PMID: 11391713
-
Disseminated non-Hodgkin's lymphoma and chronic hepatitis C: a case report.Ann Ital Med Int. 2003 Oct-Dec;18(4):246-9. Ann Ital Med Int. 2003. PMID: 14971713
Cited by
-
Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection.Viral Immunol. 2010 Oct;23(5):487-95. doi: 10.1089/vim.2010.0010. Viral Immunol. 2010. PMID: 20883163 Free PMC article.
-
Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.Immunology. 2009 Oct;128(2):227-35. doi: 10.1111/j.1365-2567.2009.03106.x. Immunology. 2009. PMID: 19740379 Free PMC article.
-
Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.PLoS Med. 2019 Sep 13;16(9):e1002894. doi: 10.1371/journal.pmed.1002894. eCollection 2019 Sep. PLoS Med. 2019. PMID: 31518344 Free PMC article.
-
Hepatitis C Virus Infection Is Associated With an Increased Risk of Active Tuberculosis Disease: A Nationwide Population-Based Study.Medicine (Baltimore). 2015 Aug;94(33):e1328. doi: 10.1097/MD.0000000000001328. Medicine (Baltimore). 2015. PMID: 26287416 Free PMC article.
-
Pan-serological antibodies and liver cancer risk: a nested case-control analysis.Sci Rep. 2025 Feb 14;15(1):5450. doi: 10.1038/s41598-025-89629-2. Sci Rep. 2025. PMID: 39953193 Free PMC article.
LinkOut - more resources
Full Text Sources
